Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001168404-21-000001
Filing Date
2021-02-17
Accepted
2021-02-17 12:33:08
Documents
1
Effectiveness Date
2021-02-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13381
  Complete submission text file 0001168404-21-000001.txt   14508
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Filer) CIK: 0001445499 (see all company filings)

EIN.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-389647 | Film No.: 21643617
SIC: 2834 Pharmaceutical Preparations